Percutaneous Dilatational Tracheostomy in Patients Receiving Dual Antiplatelet Therapy-Reference-Cited by-同舟云学术

Percutaneous Dilatational Tracheostomy in Patients Receiving Dual Antiplatelet Therapy

Published:2024-03-01 Issue:3 Volume:150 Page:273
ISSN:2168-6181
Container-title:JAMA Otolaryngology–Head & Neck Surgery
language:en
Short-container-title:JAMA Otolaryngol Head Neck Surg

Author:

Noy Roee¹²,Shkedy Yotam¹²,Simchon Omri³,Gvozdev Natalia¹,Epstein Danny²⁴

Affiliation:

1. Department of Otolaryngology–Head and Neck Surgery, Rambam Health Care Campus, Haifa, Israel

2. Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel

3. Department of Anesthesiology, Rambam Health Care Campus, Haifa, Israel

4. Critical Care Division, Rambam Health Care Campus, Haifa, Israel

Abstract

This cohort study investigates bleeding and mortality outcomes of percutaneous dilatational tracheostomy among critically ill patients receiving dual antiplatelet therapy.

Publisher

American Medical Association (AMA)

Link

https://jamanetwork.com/journals/jamaotolaryngology/articlepdf/2814294/jamaotolaryngology_noy_2024_ld_230013_1709142496.83652.pdf

Reference6 articles.

1. State of the art: percutaneous tracheostomy in the intensive care unit.;Ghattas;J Thorac Dis,2021

2. Cardiovascular risks associated with gender and aging.;Rodgers;J Cardiovasc Dev Dis,2019

3. Management of anticoagulant and antiplatelet therapy in patients undergoing interventional pulmonary procedures.;Pathak;Eur Respir Rev,2017

4. Tracheostomy in adult intensive care unit: an ISCCM expert panel practice recommendations.;Gupta;Indian J Crit Care Med,2020

5. Percutaneous dilational tracheostomy in patients receiving antiplatelet therapy: is it safe?;Abouzgheib;J Bronchology Interv Pulmonol,2013